Clinical Trials Browser

Phase 2 × Glioblastoma × Cetuximab × Clear all

NCT01044225 2012-03-22

Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma

Phase 2 Terminated

Glioblastoma